Investment Centers of America’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-854
Closed -$274K 38
2017
Q3
$274K Buy
+854
New +$253K 0.02% 456
2017
Q2
Sell
-892
Closed -$241K 599
2017
Q1
$241K Sell
892
-24
-3% -$6.79K 0.02% 525
2016
Q4
$258K Buy
+916
New +$272K 0.02% 471
2016
Q2
Sell
-956
Closed -$248K 512
2016
Q1
$248K Buy
+956
New +$253K 0.03% 404
2015
Q3
Sell
-585
Closed -$238K 458
2015
Q2
$238K Sell
585
-67
-10% -$26.9K 0.04% 355
2015
Q1
$276K Buy
+652
New +$257K 0.04% 343

Other funds holding BIIB

Investment Centers of America's BIIB Position: Q4 2017 in Review

Investment Centers of America sold out of Biogen (BIIB) in Q4 2017, closing a stake of 854 shares — an estimated $274K sold.

Investment Centers of America first reported a position in BIIB in Q1 2015 and held it in 6 quarters. The position peaked at $276K in Q1 2015. 1,122 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

  • Investment Centers of America reported no remaining Biogen position as of Q4 2017 after selling out during the quarter.
  • Investment Centers of America sold 854 Biogen shares in Q4 2017, an estimated $274K.
  • Investment Centers of America first reported a position in Biogen in Q1 2015 and held it in 6 quarters.
  • Investment Centers of America's Biogen position peaked at $276K in Q1 2015.
  • 1,122 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on Investment Centers of America's 13F filing for Q4 2017, filed 14 Feb 2018.